Cargando…

Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis

Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death. Numerous processes are involved in the pathogenesis of atherosclerosis, including inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism disorders. Reverse tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Poznyak, Anastasia V., Kashirskikh, Dmitry A., Sukhorukov, Vasily N., Kalmykov, Vladislav, Omelchenko, Andrey V., Orekhov, Alexander N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836120/
https://www.ncbi.nlm.nih.gov/pubmed/35163256
http://dx.doi.org/10.3390/ijms23031332
_version_ 1784649598667587584
author Poznyak, Anastasia V.
Kashirskikh, Dmitry A.
Sukhorukov, Vasily N.
Kalmykov, Vladislav
Omelchenko, Andrey V.
Orekhov, Alexander N.
author_facet Poznyak, Anastasia V.
Kashirskikh, Dmitry A.
Sukhorukov, Vasily N.
Kalmykov, Vladislav
Omelchenko, Andrey V.
Orekhov, Alexander N.
author_sort Poznyak, Anastasia V.
collection PubMed
description Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death. Numerous processes are involved in the pathogenesis of atherosclerosis, including inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism disorders. Reverse transport of cholesterol is a mechanism presumably underlying the atheroprotective effect of high-density lipoprotein. In this review, we examined disorders of cholesterol metabolism and their possible effect on atherogenesis. We paid special attention to the reverse transport of cholesterol. Transformed cholesterol metabolism results in dyslipidemia and early atherosclerosis. Reverse cholesterol transport is an endogenous mechanism by which cells export cholesterol and maintain homeostasis. It is known that one of the main factors leading to the formation of atherosclerotic plaques on the walls of blood vessels are multiple modifications of low-density lipoprotein, and the formation of foam cells following them.
format Online
Article
Text
id pubmed-8836120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88361202022-02-12 Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis Poznyak, Anastasia V. Kashirskikh, Dmitry A. Sukhorukov, Vasily N. Kalmykov, Vladislav Omelchenko, Andrey V. Orekhov, Alexander N. Int J Mol Sci Review Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death. Numerous processes are involved in the pathogenesis of atherosclerosis, including inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism disorders. Reverse transport of cholesterol is a mechanism presumably underlying the atheroprotective effect of high-density lipoprotein. In this review, we examined disorders of cholesterol metabolism and their possible effect on atherogenesis. We paid special attention to the reverse transport of cholesterol. Transformed cholesterol metabolism results in dyslipidemia and early atherosclerosis. Reverse cholesterol transport is an endogenous mechanism by which cells export cholesterol and maintain homeostasis. It is known that one of the main factors leading to the formation of atherosclerotic plaques on the walls of blood vessels are multiple modifications of low-density lipoprotein, and the formation of foam cells following them. MDPI 2022-01-25 /pmc/articles/PMC8836120/ /pubmed/35163256 http://dx.doi.org/10.3390/ijms23031332 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Poznyak, Anastasia V.
Kashirskikh, Dmitry A.
Sukhorukov, Vasily N.
Kalmykov, Vladislav
Omelchenko, Andrey V.
Orekhov, Alexander N.
Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
title Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
title_full Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
title_fullStr Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
title_full_unstemmed Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
title_short Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
title_sort cholesterol transport dysfunction and its involvement in atherogenesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836120/
https://www.ncbi.nlm.nih.gov/pubmed/35163256
http://dx.doi.org/10.3390/ijms23031332
work_keys_str_mv AT poznyakanastasiav cholesteroltransportdysfunctionanditsinvolvementinatherogenesis
AT kashirskikhdmitrya cholesteroltransportdysfunctionanditsinvolvementinatherogenesis
AT sukhorukovvasilyn cholesteroltransportdysfunctionanditsinvolvementinatherogenesis
AT kalmykovvladislav cholesteroltransportdysfunctionanditsinvolvementinatherogenesis
AT omelchenkoandreyv cholesteroltransportdysfunctionanditsinvolvementinatherogenesis
AT orekhovalexandern cholesteroltransportdysfunctionanditsinvolvementinatherogenesis